BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3493229)

  • 1. Suppressive effect of thymosin fraction 5 on proliferation of cultured human T lymphocytes.
    Wolf RE; Maca RD
    Immunopharmacology; 1986 Dec; 12(3):233-40. PubMed ID: 3493229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of prostaglandins on the proliferation of cultured human T lymphocytes.
    Maca RD
    Immunopharmacology; 1983 Dec; 6(4):267-77. PubMed ID: 6317610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
    Chouaib S; Welte K; Mertelsmann R; Dupont B
    J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 inhibits human T-cell proliferation after crosslinking of the CD3-Ti complex by directly affecting T cells at an early step of the activation process.
    Vercammen C; Ceuppens JL
    Cell Immunol; 1987 Jan; 104(1):24-36. PubMed ID: 2948675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combined effect of prostaglandin E2 and interleukin 1 on interleukin 2 production and lymphocyte proliferation.
    Maca RD
    Int J Immunopharmacol; 1987; 9(5):611-8. PubMed ID: 3497889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production.
    Walker C; Kristensen F; Bettens F; deWeck AL
    J Immunol; 1983 Apr; 130(4):1770-3. PubMed ID: 6601136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of human B cell activation by prostaglandin E2. Suppression of the generation of immunoglobulin-secreting cells.
    Jelinek DF; Thompson PA; Lipsky PE
    J Clin Invest; 1985 Apr; 75(4):1339-49. PubMed ID: 3872889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of indomethacin and interleukin-2 on the proliferation of lymphocytes from patients with lung cancer.
    Maca RD; Burford JG; Taylor RT
    J Clin Immunol; 1985 May; 5(3):158-65. PubMed ID: 3874210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of cyclic nucleotides on the proliferation of cultured human T-lymphocytes.
    Maca RD
    Immunopharmacology; 1984 Oct; 8(2):53-60. PubMed ID: 6096309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2.
    Braun DP; Harris JE
    J Biol Response Mod; 1984 Oct; 3(5):533-40. PubMed ID: 6239013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the immunoregulatory properties of thymosin alpha 1 on interleukin-2 production and interleukin-2 receptor expression in normal human lymphocytes.
    Sztein MB; Serrate SA
    Int J Immunopharmacol; 1989; 11(7):789-800. PubMed ID: 2599716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease.
    Zamkoff KW; Reeves WG; Paolozzi FP; Poiesz BJ; Comis RL; Tomar RH
    Clin Immunol Immunopathol; 1985 Apr; 35(1):111-24. PubMed ID: 3922653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacologic regulation of interleukin-1 production: the role of prostaglandins.
    Otterness IG; Bliven ML; Eskra JD; Reinke M; Hanson DC
    Cell Immunol; 1988 Jul; 114(2):385-97. PubMed ID: 2968844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of human B cell proliferation by prostaglandin E2.
    Thompson PA; Jelinek DF; Lipsky PE
    J Immunol; 1984 Nov; 133(5):2446-53. PubMed ID: 6332851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of prostaglandin E2 in immune suppression following injury.
    Grbic JT; Mannick JA; Gough DB; Rodrick ML
    Ann Surg; 1991 Sep; 214(3):253-62; discussion 262-3. PubMed ID: 1929607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of indomethacin on T lymphocyte stimulation.
    Kingston AE; Ivanyi J; Kay JE
    Immunol Lett; 1984; 8(6):301-5. PubMed ID: 6335488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones.
    Sztein MB; Serrate SA; Goldstein AL
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6107-11. PubMed ID: 3090550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2 inhibits the generation of phytohemagglutinin-activated killer activity in human peripheral blood lymphocytes.
    Yamashita N; Ito M; Suzuki H; Sugiyama E; Yokoyama A; Sato M; Yano S
    Anticancer Res; 1986; 6(5):1113-6. PubMed ID: 3492171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phytohemagglutin-stimulated human T cell: prothymosin alpha as an accessory signal.
    Cordero OJ; Sarandeses CS; Nogueira M
    J Biol Regul Homeost Agents; 1990; 4(1):7-12. PubMed ID: 2399834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory effects of indomethacin and prostaglandin E2 on primary and secondary antibody response in growing layer hens.
    Sijben JW; Schrama JW; Nieuwland MG; Parmentier HK
    Poult Sci; 2000 Jul; 79(7):949-55. PubMed ID: 10901192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.